Skip to content

Clinical trials

Phase 3 Psoriasis trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Psoriasis Phase: Phase 3 Country / region: Japan Clear all

43 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20101
20116
20125
20133
20142
20152
20175
20185
20193
20202
20212
20222
20243
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed36
Active, not recruiting4
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie7
Novartis Pharmaceuticals6
Eli Lilly and Company5
Janssen Pharmaceutical K.K.5
Bristol-Myers Squibb4
Kyowa Kirin Co., Ltd.4
Pfizer3
UCB Biopharma SRL3
Alumis Inc1
Amgen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Psoriasis43
Arthritis, Psoriatic7
Dermatitis4
Plaque, Amyloid4
Bronchiolitis Obliterans Syndrome3
Lymphoma, Follicular3
Arthritis2
Joint Diseases2
Musculoskeletal Diseases2
Pruritus1

Trials

Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.